These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24555530)

  • 1. Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi.
    Tweya H; Ben-Smith A; Kalulu M; Jahn A; Ng'ambi W; Mkandawire E; Gabriel L; Phiri S
    BMC Public Health; 2014 Feb; 14():183. PubMed ID: 24555530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.
    Tweya H; Feldacker C; Phiri S; Ben-Smith A; Fenner L; Jahn A; Kalulu M; Weigel R; Kamba C; Banda R; Egger M; Keiser O
    PLoS One; 2013; 8(2):e56248. PubMed ID: 23457534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: findings from an integrated HIV/TB clinic.
    Feldacker C; Tweya H; Keiser O; Weigel R; Kalulu M; Fenner L; Egger M; Manda E; Mwafilaso JB; Kamba C; Phiri S
    Trop Med Int Health; 2012 Sep; 17(9):1108-16. PubMed ID: 22808948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing and uptake of ART during treatment for active tuberculosis in HIV co-infected adults in Malawi.
    van Lettow M; Chan AK; Ginsburg AS; Tweya H; Gareta D; Njala J; Kanyerere H; Phiri S; Idana I
    Public Health Action; 2011 Sep; 1(1):6-9. PubMed ID: 26392926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High uptake of antiretroviral therapy among HIV-positive TB patients receiving co-located services in Swaziland.
    Pathmanathan I; Pasipamire M; Pals S; Dokubo EK; Preko P; Ao T; Mazibuko S; Ongole J; Dhlamini T; Haumba S
    PLoS One; 2018; 13(5):e0196831. PubMed ID: 29768503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.
    Zachariah R; Harries AD; Manzi M; Gomani P; Teck R; Phillips M; Firmenich P
    PLoS One; 2006 Dec; 1(1):e121. PubMed ID: 17205125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early versus delayed initiation of antiretroviral therapy for Indian HIV-Infected individuals with tuberculosis on antituberculosis treatment.
    Sinha S; Shekhar RC; Singh G; Shah N; Ahmad H; Kumar N; Sharma SK; Samantaray JC; Ranjan S; Ekka M; Sreenivas V; Mitsuyasu RT
    BMC Infect Dis; 2012 Jul; 12():168. PubMed ID: 22846195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the timing of antiretroviral therapy initiation in HIV-infected patients with tuberculosis in Uganda: a study of the diffusion of evidence into practice in the global response to HIV/AIDS.
    Vijayan T; Semitala FC; Matsiko N; Elyanu P; Namusobya J; Havlir DV; Kamya M; Geng EH
    Clin Infect Dis; 2013 Dec; 57(12):1766-72. PubMed ID: 24065326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control study.
    Peck RN; Luhanga A; Kalluvya S; Todd J; Lugoba S; Fitzgerald DW; Downs JA
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1047-51. PubMed ID: 22691942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
    Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
    Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Chimsuntorn S; Sungkanuparph S
    HIV Med; 2008 May; 9(5):294-9. PubMed ID: 18400076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment uptake in patients with HIV-associated TB attending co-located TB and ART services.
    Nglazi MD; Kaplan R; Caldwell J; Peton N; Lawn SD; Wood R; Bekker LG
    S Afr Med J; 2012 Oct; 102(12):936-9. PubMed ID: 23498041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment.
    Yotebieng M; Van Rie A; Moultrie H; Cole SR; Adimora A; Behets F; Meyers T
    AIDS; 2010 Jun; 24(9):1341-9. PubMed ID: 20559039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated therapy for HIV and tuberculosis.
    Manosuthi W; Wiboonchutikul S; Sungkanuparph S
    AIDS Res Ther; 2016; 13():22. PubMed ID: 27182275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month mortality among HIV-infected adults presenting for antiretroviral therapy with unexplained weight loss, chronic fever or chronic diarrhea in Malawi.
    van Lettow M; Åkesson A; Martiniuk AL; Ramsay A; Chan AK; Anderson ST; Harries AD; Corbett E; Heyderman RS; Zachariah R; Bedell RA
    PLoS One; 2012; 7(11):e48856. PubMed ID: 23185278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study.
    Varma JK; Nateniyom S; Akksilp S; Mankatittham W; Sirinak C; Sattayawuthipong W; Burapat C; Kittikraisak W; Monkongdee P; Cain KP; Wells CD; Tappero JW
    BMC Infect Dis; 2009 Apr; 9():42. PubMed ID: 19364398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operational research in Malawi: making a difference with cotrimoxazole preventive therapy in patients with tuberculosis and HIV.
    Harries AD; Zachariah R; Chimzizi R; Salaniponi F; Gausi F; Kanyerere H; Schouten EJ; Jahn A; Makombe SD; Chimbwandira FM; Mpunga J
    BMC Public Health; 2011 Jul; 11():593. PubMed ID: 21794154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial.
    Chabala C; Turkova A; Thomason MJ; Wobudeya E; Hissar S; Mave V; van der Zalm M; Palmer M; Kapasa M; Bhavani PK; Balaji S; Raichur PA; Demers AM; Hoddinott G; Owen-Powell E; Kinikar A; Musoke P; Mulenga V; Aarnoutse R; McIlleron H; Hesseling A; Crook AM; Cotton M; Gibb DM;
    Trials; 2018 Apr; 19(1):237. PubMed ID: 29673395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus-associated tuberculosis care in Botswana: evidence from a real-world setting.
    Muyaya LM; Musanda EM; Tamuzi JL
    BMC Infect Dis; 2019 Sep; 19(1):767. PubMed ID: 31477055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.